| Literature DB >> 34031053 |
Adriana M Rauseo1, Patrick Mazi1, Phoebe Lewis2, Bruce Burnett2, Stuart Mudge2, Andrej Spec1.
Abstract
Conventional itraconazole (C-ITZ) suffers from absorption variability. SUBA-itraconazole (S-ITZ) is more bioavailable than C-ITZ at steady state in a fed condition, but there are no data comparing the two under a fasted state. An open-label, single-dose, randomized, bioequivalence study was performed comparing S-ITZ to C-ITZ capsules under fasted and fed conditions in healthy adults measuring itraconazole and hydroxyitraconazole plasma levels. This study demonstrated less variability of S-ITZ compared to C-ITZ capsules under fasted conditions.Entities:
Keywords: bioavailability; endemic mycoses; itraconazole; pharmacokinetics
Mesh:
Substances:
Year: 2021 PMID: 34031053 PMCID: PMC8284459 DOI: 10.1128/AAC.00134-21
Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN: 0066-4804 Impact factor: 5.191